Edwards Lifesciences CorporationEWNYSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-4.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -68.67% |
| Q3 2025 | -11.73% |
| Q2 2025 | -7.88% |
| Q1 2025 | -7.16% |
| Q4 2024 | -87.44% |
| Q3 2024 | 744.32% |
| Q2 2024 | 3.35% |
| Q1 2024 | -4.87% |
| Q4 2023 | -3.90% |
| Q3 2023 | 25.33% |
| Q2 2023 | -9.81% |
| Q1 2023 | -14.53% |
| Q4 2022 | 15.98% |
| Q3 2022 | -15.48% |
| Q2 2022 | 8.78% |
| Q1 2022 | 11.42% |
| Q4 2021 | -1.41% |
| Q3 2021 | -30.52% |
| Q2 2021 | 44.74% |
| Q1 2021 | 9.27% |
| Q4 2020 | -4.83% |
| Q3 2020 | 366.78% |
| Q2 2020 | -139.25% |
| Q1 2020 | 10.85% |
| Q4 2019 | 2.00% |
| Q3 2019 | 13.37% |
| Q2 2019 | -2.96% |
| Q1 2019 | 3467.14% |
| Q4 2018 | -96.90% |
| Q3 2018 | -20.09% |
| Q2 2018 | 36.83% |
| Q1 2018 | 478.71% |
| Q4 2017 | -79.01% |
| Q3 2017 | -8.60% |
| Q2 2017 | -19.16% |
| Q1 2017 | 45.24% |
| Q4 2016 | 12.09% |
| Q3 2016 | 11.69% |
| Q2 2016 | -11.47% |
| Q1 2016 | 1.63% |